As of 2025-05-03, the Intrinsic Value of Healthcare Global Enterprises Ltd (HCG.NS) is 168.58 INR. This HCG.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 573.55 INR, the upside of Healthcare Global Enterprises Ltd is -70.60%.
The range of the Intrinsic Value is 113.01 - 271.26 INR
Based on its market price of 573.55 INR and our intrinsic valuation, Healthcare Global Enterprises Ltd (HCG.NS) is overvalued by 70.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 113.01 - 271.26 | 168.58 | -70.6% |
| DCF (Growth 10y) | 203.80 - 419.03 | 280.03 | -51.2% |
| DCF (EBITDA 5y) | 414.28 - 637.22 | 499.97 | -12.8% |
| DCF (EBITDA 10y) | 465.32 - 763.61 | 581.35 | 1.4% |
| Fair Value | 20.92 - 20.92 | 20.92 | -96.35% |
| P/E | 91.95 - 173.92 | 131.86 | -77.0% |
| EV/EBITDA | 217.43 - 420.12 | 293.37 | -48.8% |
| EPV | 34.56 - 67.17 | 50.87 | -91.1% |
| DDM - Stable | 26.54 - 62.91 | 44.73 | -92.2% |
| DDM - Multi | 106.55 - 198.51 | 138.90 | -75.8% |
| Market Cap (mil) | 79,964.34 |
| Beta | 0.37 |
| Outstanding shares (mil) | 139.42 |
| Enterprise Value (mil) | 92,761.74 |
| Market risk premium | 8.31% |
| Cost of Equity | 12.51% |
| Cost of Debt | 12.86% |
| WACC | 11.89% |